Abstract

This chapter discusses the hyperlipoproteinemia types II and III, the two forms of hyperlipidemia that are of greatest significance from the point of view of the metabolism of cholesterol, with main emphasis on the familial forms of these disorders. Hyperlipidemia refers to a raised plasma concentration of cholesterol or triglyceride or of both. Although measurement of plasma total cholesterol and total triglyceride concentrations is essential as a first step in the diagnosis of a plasma lipid disorder, and may in some cases be adequate as a guide to treatment, it cannot give decisive information about the abnormal plasma lipoprotein pattern responsible for the hyperlipidaemia. It is, therefore, much more informative to consider a raised plasma lipid concentration as the expression of a raised concentration of one or more plasma lipoprotein fractions (hyperlipoproteinemia), defined in terms of cut-off points. The hyperlipoproteinemias are classified in accordance with the recommendations of the World Health Organization (WHO) into the six types. The abnormal lipoprotein patterns may be primary, or they may be secondary to one or other of the conditions listed by the WHO.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.